Login to Your Account

Pharma: Other News To Note

Monday, August 19, 2013
The FDA approved Glaxosmithkline plc's Flulaval Quadrivalent (Influenza Virus Vaccine) for immunization of people older than 3 for seasonal influenza virus subtypes A and B. Flulaval is the London-based GSK's second intramuscular quadrivalent vaccine approved by the FDA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription